☆ 3.8 Article

Facial and Abducens Nerve Palsies Following COVID-19 Vaccination: Report of Two Cases

NEURO-OPHTHALMOLOGY (2022)

Related references

Note: Only part of the references are listed.

Article Infectious Diseases

Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study

Eric Yuk Fai Wan et al.

Summary: The study evaluated the risk of Bell's palsy after vaccination with BNT162b2 and CoronaVac, finding an increased risk of Bell's palsy following CoronaVac vaccination. However, the overall benefits and protective effects of the inactivated COVID-19 vaccine far outweigh the risk of this generally self-limiting adverse event.

LANCET INFECTIOUS DISEASES (2022)

Add to Collection

Editorial Material Clinical Neurology

Cranial Nerve III Palsy in the Setting of COVID-19 Infection

John C. Fitzpatrick et al.

JOURNAL OF NEURO-OPHTHALMOLOGY (2021)

Add to Collection

Editorial Material Cell Biology

Adverse Ocular Events following COVID-19 Vaccination

Taher K. Eleiwa et al.

INFLAMMATION RESEARCH (2021)

Add to Collection

Article Infectious Diseases

Facial nerve palsy following the administration of COVID-19 mRNA vaccines: analysis of a self-reporting database

Kenichiro Sato et al.

Summary: A study investigated cases of facial nerve palsy following COVID-19 mRNA vaccines using the VAERS database and found the adverse event to be significantly higher reported compared to influenza vaccines, but possibly lower or equivalent in incidence.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection

Article Ophthalmology

Acute abducens nerve palsy following COVID-19 vaccination

Daniela P. Reyes-Capo et al.

Summary: This case report describes a healthy 59-year-old woman who developed acute abducens nerve palsy 2 days after receiving the Pfizer-BioNTech COVID-19 vaccine. The temporal relationship between vaccination and symptom onset suggests a potential link between the vaccine and neurologic complications.

JOURNAL OF AAPOS (2021)

Add to Collection

Article Ophthalmology

Acute Abducens Nerve Palsy Following the Second Dose of the AstraZeneca COVID-19 Vaccine

Arpitha Pereira et al.

Summary: The case of a 65-year-old man who developed abducens nerve palsy after receiving the AstraZeneca COVID-19 vaccine highlights the potential neurologic adverse effects associated with vaccination.

JOURNAL OF PEDIATRIC OPHTHALMOLOGY & STRABISMUS (2021)

Add to Collection

Article Otorhinolaryngology

Association of COVID-19 Vaccination and Facial Nerve Palsy A Case-Control Study

Asaf Shemer et al.

Summary: This case-control study found no association between recent vaccination with the BNT162b2 vaccine and the risk of facial nerve palsy. The analysis of data from previous years also showed a relatively stable trend in the number of admissions for facial nerve palsy patients.

JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2021)

Add to Collection

Article Immunology

Association between Influenza Vaccination and the Risk of Bell's Palsy in the Korean Elderly

Nayoung Jeong et al.

Summary: The study found no evidence of an increased risk of Bell's palsy after influenza vaccination in the elderly population, providing reassurance about the safety of the influenza vaccine. Continuous monitoring of the risk of Bell's palsy during future flu seasons is necessary for further research.

VACCINES (2021)

Add to Collection

Article Ophthalmology

Acute abducens nerve palsy after COVID-19 vaccination in a young adult

Neelam Pawar et al.

Summary: This case report highlights a 23-year-old male who developed abducens nerve palsy following COVID-19 vaccination, with a confirmed association. It serves as a reminder for ophthalmologists to be aware of potential neurological sequelae following vaccination in young adults.

INDIAN JOURNAL OF OPHTHALMOLOGY (2021)

Add to Collection

Article Immunology

Bell's Palsy after second dose of Pfizer COVID-19 vaccination in a patient with history of recurrent Bell's palsy

Michael Repajic et al.

Summary: A 57-year-old female with history of recurrent Bell's Palsy developed left Bell's Palsy less than 36 hours after receiving the second dose of the Pfizer-BioNTech COVID-19 vaccine. The symptoms progressed in severity over the next 72 hours, suggesting a possible association between vaccine administration and onset of symptomatic Bell's Palsy. Further investigation may be warranted due to reports of Bell's Palsy in trials of both Moderna and Pfizer vaccines.

BRAIN, BEHAVIOR, & IMMUNITY - HEALTH (2021)

Add to Collection

Editorial Material Clinical Neurology

COVID-19 presenting with ophthalmoparesis from cranial nerve palsy

Marc Dinkin et al.

NEUROLOGY (2020)

Add to Collection

Review Clinical Neurology

Isolated Abducens Nerve Palsy: Update on Evaluation and Diagnosis

Christopher Elder et al.

CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2016)

Add to Collection

Article Surgery

Bell's Palsy

Kavita Vakharia et al.

FACIAL PLASTIC SURGERY CLINICS OF NORTH AMERICA (2016)

Add to Collection

Review Clinical Neurology

Bell's palsy: aetiology, clinical features and multidisciplinary care

Timothy J. Eviston et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2015)

Add to Collection

Article Biotechnology & Applied Microbiology

Motor palsies of cranial nerves (excluding VII) after vaccination Reports to the US Vaccine Adverse Event Reporting System

Emily Jane Woo et al.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)

Add to Collection

Article Ophthalmology

Clinical features and natural history of acquired third, fourth, and sixth cranial nerve palsy

U-C Park et al.

EYE (2008)

Add to Collection

Article Ophthalmology

Incidence, associations, and evaluation of sixth nerve palsy using a population-based method

SV Patel et al.

OPHTHALMOLOGY (2004)

Add to Collection

Article Medicine, General & Internal

Cranial and peripheral neuropathies

JM Spies

MEDICAL JOURNAL OF AUSTRALIA (2001)

Add to Collection

© Peeref 2019-2024. All rights reserved.